588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Treosulfan Acute Myeloid Leukemia	Institut Paoli-Calmettes	P3	B (63)
Ziftomenib Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P3	B (63)
Apamistamab Acute Myeloid Leukemia	Actinium Pharmaceuticals	P3	B (62)
Azacytidine Acute Myeloid Leukemia	Janssen Research & Development, LLC	P3	B (62)
Epoetin Alfa Acute Myeloid Leukemia	National Cancer Institute (NCI)	P3	B (62)
Equine Atg Acute Myeloid Leukemia	Shanxi Bethune Hospital	P3	B (62)
Ipilimumab Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P2	B (62)
Isavuconazole Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2/3	B (62)
Midostaurin Acute Myeloid Leukemia	Richard Stone, MD	P3	B (62)
Nivolumab Acute Myeloid Leukemia	Ludwig-Maximilians - University of Munich	P2/3	B (62)
Nogitecan Acute Myeloid Leukemia	Norman J. Lacayo	P4	B (62)
Rituximab Acute Myeloid Leukemia	Prelude Therapeutics	P3	B (62)
Voriconazole Acute Myeloid Leukemia	Sohag University	P3	B (62)
Anti-Cd33 Monoclonal Antibody Bi 836858 Acute Myeloid Leukemia	Philogen S.p.A.	P1/2	B (61)
Basiliximab Acute Myeloid Leukemia	City of Hope Medical Center	P2	B (61)
Ceftazidime Acute Myeloid Leukemia	Gadjah Mada University	P4	B (61)
Cpx-351 Acute Myeloid Leukemia	National Cancer Institute (NCI)	P4	B (61)
Crisantaspase Acute Myeloid Leukemia	Joanna Yi	P3	B (61)
Furosemide Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	B (61)
Hht Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (61)
Ivosidenib Acute Myeloid Leukemia	French Innovative Leukemia Organisation	P3	B (61)
Sirolimus Acute Myeloid Leukemia	City of Hope Medical Center	P3	B (61)
Sorafenib Acute Myeloid Leukemia	The First Affiliated Hospital of Soochow University	P3	B (61)
Abatacept Recombinant Acute Myeloid Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P3	B (60)
Adriamycin Acute Myeloid Leukemia	Janssen Research & Development, LLC	P3	B (60)
Allopurinol Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P2	B (60)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Acute Myeloid Leukemia	The First Affiliated Hospital of Soochow University	P4	B (60)
Clofarabine Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P3	B (60)
Dfp-10917 Acute Myeloid Leukemia	Delta-Fly Pharma, Inc.	P3	B (60)
Immunoglobulin G1 Anti-(Human Cd33 (Antigen)) (Human-Mouse Monoclonal Hum195 .Gamma.1-Chain), Disulfide With Human Monoclonal Hum195 .Kappa.-Chain, Dimer Acute Myeloid Leukemia	Actinium Pharmaceuticals	P2	B (60)
Lenalidomide Acute Myeloid Leukemia	Medical College of Wisconsin	P4	B (60)
Prednisolone Acute Myeloid Leukemia	Children's Oncology Group	P2	B (60)
Recombinant Human Granulocyte Colony-Stimulating Factor Acute Myeloid Leukemia	City of Hope Medical Center	P2	B (60)
Ventoclax Acute Myeloid Leukemia	Guangdong Second Provincial General Hospital	P2/3	B (60)
Astarabine Acute Myeloid Leukemia	BioSight Ltd.	P2	B (59)
Bortezomib Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P3	B (59)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester) Acute Myeloid Leukemia	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	P3	B (59)
Enasidenib Acute Myeloid Leukemia	National Cancer Institute (NCI)	P3	B (59)
Ruxolitinib Acute Myeloid Leukemia	Stephan Grupp MD PhD	P4	B (59)
Tucidinostat Acute Myeloid Leukemia	Dongguan People's Hospital	P2	B (59)
Asparaginase Acute Myeloid Leukemia	Sanofi	P3	B (58)
Blinatumomab Acute Myeloid Leukemia	Ascentage Pharma Group Inc.	P2	B (58)
Cedazuridine Acute Myeloid Leukemia	National Cancer Institute (NCI)	P3	B (58)
Cobicistat Acute Myeloid Leukemia	Stichting Hemato-Oncologie voor Volwassenen Nederland	P2	B (58)
Cusatuzumab Acute Myeloid Leukemia	OncoVerity, Inc.	P2	B (58)
Daratumumab Acute Myeloid Leukemia	City of Hope Medical Center	P2	B (58)
Dasatinib Acute Myeloid Leukemia	Institut Paoli-Calmettes	P3	B (58)
Dc/Aml Fusion Vaccine Acute Myeloid Leukemia	David Avigan	P2	B (58)
Emavusertib Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	B (58)
Galinpepimut-S Acute Myeloid Leukemia	Sellas Life Sciences Group	P3	B (58)

Showing 51 to 100 of 588 assets

PreviousPage 2 of 12Next